The Label Under the Microscope: A 2026 UK Shopper's Guide to CBD Verification

Walk into almost any independent health food shop in Britain this autumn and you will meet a wall of tinctures, gummies and capsules, each one wrapped in confident typography and soft botanical imagery. The packaging is polished. The small print, however, is where the genuinely useful information sits. For a category that straddles food law, medicines regulation and a good deal of retail improvisation, the label is often the only evidence a shopper has before spending £30 or more on a 10ml bottle.

This guide is not a recommendation of any brand. It is a method: a way of reading a CBD product label the way a cautious purchaser should, plus a short checklist you can carry into a high street shop or apply at an online checkout.

Start with the legal baseline

Under UK law, cannabidiol sold for ingestion is treated as a novel food. The Food Standards Agency maintains a public register of products whose applications have reached a defined stage in that process. As of 2026, this register remains the single most useful legal reference point for a shopper. A product that cannot be traced to it — or whose seller cannot explain where it sits — deserves scepticism. Some lines are legitimately mid-application, but a reputable retailer should be able to say so plainly rather than change the subject.

Two further baselines matter. First, the Home Office exemption that allows CBD products to be sold without a licence rests on a strict limit on tetrahydrocannabinol, widely applied at 1mg per container. A label that declares a THC percentage but no container-level figure is giving you only half the picture. Second, UK advertising and medicines rules mean a CBD product sold over the counter cannot claim to treat, cure or prevent a disease. Language about supporting sleep or maintaining calm is tolerated; promises about anxiety disorders or chronic pain are not, and their presence is a reasonable signal of how seriously the brand takes compliance.

The certificate of analysis: batch, lab and panel

A certificate of analysis, or COA, is a laboratory report on a specific batch of product. Its value collapses if it is generic, undated or recycled across an entire range. What to look for:

• A batch number that matches the one printed on your pack.
• A testing date that falls after the manufacture date on the label, not months before it.
• The name of the laboratory, ideally accredited to ISO 17025, the international standard for testing competence.
• A cannabinoid panel listing at least CBD, CBDa, THC and THCa, plus any minor cannabinoids the brand promotes.
• Contaminant screening covering heavy metals, pesticides, mycotoxins, residual solvents and microbial counts.

Read the limit-of-detection notes. A result recorded as not detected is a stronger statement than one below the limit of quantification, and neither is the same as zero. A well-run brand will publish the full report rather than a summary graphic, and will do so without demanding an email address first.

CBD content versus hemp-seed oil

Many inexpensive products are, in substance, hemp-seed oil with a token amount of cannabidiol. Hemp seed is a pleasant, nutritious oil; it contains negligible CBD. The distinction matters because the price of a bottle is usually set by the cannabidiol, not the carrier.

Two calculations will expose most confusion. First, work out the total CBD in the container: a 10ml bottle described as 10 per cent contains roughly 1000mg, while a 30ml bottle at 5 per cent contains around 1500mg. Second, divide that total by the number of drops or millilitres to see what a serving actually delivers, then compare cost per milligram across products. A £20 bottle and a £60 bottle may work out very differently once the arithmetic is done.

Broad-spectrum, full-spectrum, isolate

These three words dominate CBD marketing and none of them has a fixed legal definition in the UK. Conventionally, an isolate is purified cannabidiol; a full-spectrum extract retains the plant's minor cannabinoids, terpenes and trace THC; broad-spectrum sits between the two, with THC removed or reduced. Because the terms are descriptive rather than regulated, the cannabinoid panel on the COA is the only reliable way to check what a product contains. If a brand leans heavily on broad-spectrum status, the report should show the minor cannabinoids and demonstrate that THC has genuinely been reduced.

A checklist for the shop floor or the checkout page

1. Is the product traceable to the FSA novel food register, or can the seller explain its status?
2. Does the pack state total CBD in milligrams, not only a percentage?
3. Is there a batch number, and is it matched by a dated COA?
4. Is the testing laboratory named and accredited?
5. Does the COA cover contaminants as well as cannabinoids?
6. Is THC declared at container level?
7. Does the marketing avoid medicinal claims?
8. Can you compare cost per milligram with two rival products in under a minute?

The limits of the label

A clean label is a necessary condition, not a guarantee of quality or of personal suitability. CBD can interact with some prescription medicines, and anyone who is pregnant, breastfeeding or taking regular medication should speak to a pharmacist or GP before starting. What the label can do is tell you whether the company behind the bottle has bothered to document its product. In a market still finding its regulatory feet, that is a reasonable proxy for care.